Immunotherapy in HNSCC Series: Ep 1 - PD-L1 testing

IMPACT Medicom

Welcome to the first episode of IMPACT Medicom’s podcast series on Immunotherapy in Head and Neck Squamous Cell Carcinomas. This episode includes a discussion of:

• The role of the pathologist in the management of head and neck cancers
• PD-L1 testing as a predictive biomarker for immunotherapy in HNSCC
• Improving the testing process for PD-L1

Our Guest:
Our guest is Dr. Matthew Cecchini, Pathologist in the Department of Pathology and Laboratory Medicine at London Health Sciences Centre and Assistant Professor at Western University in London Ontario Canada. Dr. Cecchini specializes in pulmonary, head and neck, and molecular pathology. His research interests include the application of digital and machine learning tools in pathology.
This podcast episode was sponsored by Merck Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com